Treatment of type 2 diabetes mellitus with the endoscopic duodenal-jejunal bypass liner (EndoBarrier®)
K Laubner, L Potasso, N Perakakis, H Schwacha, J Seufert · Diabetologie und Stoffwechsel · 2014 · Heft 05
Bibliografische Angaben
Zusammenfassung
Background: The duodenal-jejunal bypass liner (DJBL) is an endoscopically delivered and removable device creating a duodenal-jejunal bypass thereby mimicking Roux-en-Y and Duodenal-Jejunal Bypass procedures. The DJBL is indicated for the treatment of type 2 Diabetes (T2Dm) and obesity. Here we report interim results of the ongoing data collection of patients treated with this procedure. Methods: We implanted in 26 subjects with T2Dm (f:m 21:5, 46,3 y) on various medications, a mean baseline HbA1c of 7,7% and BMI of 44,7 kg/m2 a DJBL. AEs as well as anthropometric, metabolic and cardiovascular risk parameters wer…